reports
- Aurelien Sivignon
- Martijn Den Drijver
- Olfa Taamallah
- Yan Derocles
Oculis Announces Oversubscribed $110 Million Financing to Accelerate P...
Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced the pricing of offerings of an aggregate of 5,432,098 of its ordinary shares, CHF 0.01 nominal value per share, at a price of $20.25 per share for total gross proceeds of $110 million before deducting under...
Oculis greinir frá umframeftirspurn í 110 milljóna USD fjármögnun sem ...
Oculis greinir frá umframeftirspurn í 110 milljóna USD fjármögnun sem er ætlað til að hraða klínískri þróun Privosegtor ZUG, Sviss, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) („Oculis“ eða „félagið“), alþjóðlegt líftæknilyfjafyrirtæki með áherslu á á nýsköpun til að meðhöndla augnsjúkdóma og augntaugasjúkdóma og mæta verulegum óuppfylltum læknisfræðilegum þörfum, greinir í dag frá því að ákvörðun hafi verið tekin um verð og úthlutun almennra hluta í útboði þar sem seldir voru 5.432.098 almennir hlutir, hver að nafnverði 0,01 CHF, á verðinu 20,25 USD á hlu...
- Maxime Dubreil
Norwegian Air Shuttle ASA: 4 directors
Four Directors at Norwegian Air Shuttle ASA bought/maiden bought 22,554 shares at between 15.190NOK and 15.305NOK. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the co...
- Jacob Mekhael
argenx 3Q25 results Vyvgart delivers another CSS beat
argenx' 3Q25 numbers came in solid with Vyvgart sales of $ 1.13b, delivering another beat (approx. 6.8%) on company compiled CSS ($ 1,054.8m). Product revenue consensus for FY25 currently stands at $ 3.93b, which is well within reach as PFS continues to contribute to the launch momentum. argenx reached operating profitability for the 5th consecutive quarter despite a 40% increase in opex. ACCUMULATE maintained.
- Colin Smith
Seplat Energy | 3Q25 results – strong quarter, special dividend
Results for 3Q25 bounced back QoQ and the results for the year to September further highlight the transformative impact of the SEPNU offshore acquisition, coupled with a strong performance from the legacy onshore operations. For 9M25, production jumped 185% YoY to 135.6kboed driving a 169% increase in net profit to US$95.1m, despite a 13% reduction in the realised oil price. Very strong cash generation saw net debt reduced to US$385.9m with leverage down to just 0.27x. That performance saw the c...
- Maxime Dubreil
- Andres Bolumburu
INDRA: RDOS. 9MESES’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADE...
Rdos. 3T'25 vs 3T'24: Ventas: 1.162 M euros (+6,0% vs +5,6% BS(e) y +10,7% consenso); EBIT: 109,0 M euros (-1,8% vs -0,9% BS(e) y +4,0% consenso); BDI: 77,0 M euros (+10,0% vs -1,4% BS(e) y +5,4% consenso). Rdos. 9meses'25 vs 9meses'24: Ventas: 3.611 M euros (+6,2% vs +6,1% BS(e) y +7,8% consenso); EBIT: 319,0 M euros (+10,0% vs +10,0% BS(e) y +11,9% consenso); BDI: 291,0 M euros (+58,2% vs +54,3% BS(e) y +57,0% consenso).
HYBE: 1 director
A director at HYBE sold 5,900 shares at 286,805.542KRW and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Kumho Petro Chemical: 1 director
A director at Kumho Petro Chemical bought 351 shares at 117,100.000KRW and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
- ABGSC Capital Goods Research
- Martin Mauseth
- Chris Turner
- Francesco Pesole
FX Daily: Fed discord delays dollar drop
News from Powell's press conference that the Fed has strongly differing views about the future path for policy has prompted a 10bp re-assessment of the Fed easing cycle and provided support for the dollar. Most vulnerable to firmer USD rates are the low-yielding yen and Swiss franc, whereas commodity-backed FX is welcoming a thaw in US-China relations
- Delphine Brault
- Nathan Mietlicki
- Jovan Sikimic
- Martial Descoutures
- Thijs Berkelder
Arco Vara AS Dividend Payment Ex-date
Arco Vara AS Dividend Payment Ex-date Arco Vara AS will pay its shareholders a dividend of EUR 0.02 net per share for the financial year 2024. The dividends will be paid out to shareholders on 12 November 2025. In accordance with the company’s approved dividend policy, the list of shareholders entitled to receive dividends will be fixed as of the end of the business day of the Nasdaq CSD Estonian settlement system on 5 November 2025 (record date). Consequently, the date of change in the rights related to the shares (ex-date) is 4 November 2025. Starting from the ex-date, i.e. 4 November 2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.